Hajjo, R.; Sabbah, D.A.; Alhaded, R.; Alquabe'h, A.; Bardaweel, S.K.
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib. Pharmaceuticals 2025, 18, 936.
https://doi.org/10.3390/ph18070936
AMA Style
Hajjo R, Sabbah DA, Alhaded R, Alquabe'h A, Bardaweel SK.
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib. Pharmaceuticals. 2025; 18(7):936.
https://doi.org/10.3390/ph18070936
Chicago/Turabian Style
Hajjo, Rima, Dima A. Sabbah, Raghad Alhaded, Aye Alquabe'h, and Sanaa K. Bardaweel.
2025. "Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib" Pharmaceuticals 18, no. 7: 936.
https://doi.org/10.3390/ph18070936
APA Style
Hajjo, R., Sabbah, D. A., Alhaded, R., Alquabe'h, A., & Bardaweel, S. K.
(2025). Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib. Pharmaceuticals, 18(7), 936.
https://doi.org/10.3390/ph18070936